Clinical trial
Study of the Safety of Intravenous Artesunate
NCT00292929 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00292929 |
|---|---|
| Title | Study of the Safety of Intravenous Artesunate |
| Official title | A Phase 1 Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Single Intravenous Doses of Artesunate Administered to Healthy Subjects |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria, Cerebral |
| Intervention type | Drug |
| Interventions | Intravenous artesunate |
| Enrollment | 40 |
| Completion | Oct 1, 2006 |
| First posted | Feb 16, 2006 |
| Last update posted | Oct 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: